Zigakibart Treatment Results in Rapid and Sustained Reductions in IgA and Gd-IgA1 in Patients with IgA Nephropathy

Zigakibart Treatment Results in Rapid and Sustained Reductions in IgA and Gd-IgA1 in Patients with IgA Nephropathy

Zigakibart produced rapid and sustained reductions in IgA and Gd-IgA1, the pathogenic variant of IgA nephropathy

Format

PNG

Quelle:

Chinook Therapeutics, Inc.

Downloads